Europe Gastric Cancer Diagnostic Procedure Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Gastric Cancer Diagnostic Procedure Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Gastric Cancer Diagnostic Procedure Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Gastric Cancer Diagnostic Procedure Market Regional Analysis

6.2 Europe Gastric Cancer Diagnostic Procedure Market Revenue 2020-2028 (US$ Million)

6.3 Europe Gastric Cancer Diagnostic Procedure Market Forecast Analysis

7. Europe Gastric Cancer Diagnostic Procedure Market Analysis – by Healthcare Providers

7.1 Diagnostic Laboratories

7.1.1 Overview
7.1.2 Diagnostic Laboratories: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.2 Hospitals

7.2.1 Overview
7.2.2 Hospitals: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.3 Cancer Research Institutes

7.3.1 Overview
7.3.2 Cancer Research Institutes: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

7.4 Oncology Specialty Clinics

7.4.1 Overview
7.4.2 Oncology Specialty Clinics: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

8. Europe Gastric Cancer Diagnostic Procedure Market Analysis – by Symptom Types

8.1 Symptomatic and Asymptomatic

8.1.1 Overview
8.1.2 Symptomatic and Asymptomatic: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

9. Europe Gastric Cancer Diagnostic Procedure Market Analysis – by Body Fluid

9.1 Blood

9.1.1 Overview
9.1.2 Blood: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.2 Urine

9.2.1 Overview
9.2.2 Urine: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.3 Saliva

9.3.1 Overview
9.3.2 Saliva: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.4 Stomach Wash/Gastric Juice

9.4.1 Overview
9.4.2 Stomach Wash/Gastric Juice: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

9.5 Tissue

9.5.1 Overview
9.5.2 Tissue: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

10. Europe Gastric Cancer Diagnostic Procedure Market Analysis – by Procedures

10.1 Endoscopic Procedures

10.1.1 Overview
10.1.2 Endoscopic Procedures: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.2 Biopsy & Tissue Tests

10.2.1 Overview
10.2.2 Biopsy & Tissue Tests: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.3 Lab Tests

10.3.1 Overview
10.3.2 Lab Tests: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.4 In-Vitro Diagnostic Tests

10.4.1 Overview
10.4.2 In-Vitro Diagnostic Tests: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.5 Imaging Tests

10.5.1 Overview
10.5.2 Imaging Tests: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.6 Molecular Diagnostics

10.6.1 Overview
10.6.2 Molecular Diagnostics: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

10.7 Multiplexing Molecular Diagnostics & Immunoassays

10.7.1 Overview
10.7.2 Multiplexing Molecular Diagnostics & Immunoassays: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast, 2020-2028 (US$ Million)

11. Europe Gastric Cancer Diagnostic Procedure Market – Europe Analysis

11.1 Overview

11.2 Europe

11.2.1 Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Key Country, 2023 and 2028 (%)
11.2.1.1 Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast Analysis – by Country
11.2.1.1 UK: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.1.1 UK: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Healthcare Providers
11.2.1.1.2 UK: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Symptom Types
11.2.1.1.3 UK: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Body Fluid
11.2.1.1.4 UK: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Procedures

11.2.1.2 Germany: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.2.1 Germany: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Healthcare Providers
11.2.1.2.2 Germany: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Symptom Types
11.2.1.2.3 Germany: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Body Fluid
11.2.1.2.4 Germany: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Procedures

11.2.1.3 France: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.3.1 France: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Healthcare Providers
11.2.1.3.2 France: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Symptom Types
11.2.1.3.3 France: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Body Fluid
11.2.1.3.4 France: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Procedures

11.2.1.4 Russia: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.4.1 Russia: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Healthcare Providers
11.2.1.4.2 Russia: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Symptom Types
11.2.1.4.3 Russia: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Body Fluid
11.2.1.4.4 Russia: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Procedures

11.2.1.5 Italy: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.5.1 Italy: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Healthcare Providers
11.2.1.5.2 Italy: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Symptom Types
11.2.1.5.3 Italy: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Body Fluid
11.2.1.5.4 Italy: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Procedures

11.2.1.6 Rest of Europe: Europe Gastric Cancer Diagnostic Procedure Market – Revenue and Forecast to 2028 (US$ Million)

11.2.1.6.1 Rest of Europe: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Healthcare Providers
11.2.1.6.2 Rest of Europe: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Symptom Types
11.2.1.6.3 Rest of Europe: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Body Fluid
11.2.1.6.4 Rest of Europe: Europe Gastric Cancer Diagnostic Procedure Market Breakdown, by Procedures

12. Competitive Landscape

12.1 Heat Map Analysis

12.2 Company Positioning and Concentration

13. Industry Landscape

13.1 Overview

13.2 Market Initiative

13.3 Partnerships and Collaborations

13.4 Other Developments

14. Company Profiles

14.1 Agilent Technologies Inc

14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments

14.2 Atlas-Link Biotech Co Ltd

14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments

14.3 BioMerieux SA

14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments

14.4 Bio-Rad Laboratories Inc

14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments

14.5 F. Hoffmann-La Roche Ltd

14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments

14.6 Illumina Inc

14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments

14.7 MiRXES Pte Ltd

14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments

14.8 Myraid Genetics Inc

14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments

14.9 Thermo Fisher Scientific Inc

14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments

14.10 Vela Diagnostics Holding Pte Ltd

14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments

15. Appendix

15.1 About Business Market Insights

15.2 List of Abbreviations

Europe Gastric Cancer Diagnostic Procedure Market